# Sobi to present new gout data at ACR Convergence 2026

- Source: PR Newswire M&A
- Published: 2026-11-03T08:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/sobi-to-present-new-gout-data-at-acr-convergence-2026-302927578.html
- Canonical: https://groundlevelnews.com/story/sobi-to-present-new-gout-data-at-acr-convergence-2026-2161ac/

STOCKHOLM, Nov. 3, 2026 /PRNewswire/ -- Sobi® (STO: SOBI) today announced that six abstracts covering pozdeutinurad (AR882), nanoencapsulated sirolimus plus pegadricase (NASP) and uncontrolled gout will be presented at ACR Convergence 2026, the American College of Rheumatology annual...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._